Ranibizumab
Drug timelines are a Plus or Pro feature.
169 regulatory and trial events tracked for Ranibizumab, covering 2008-11-03 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS) [Phase 4]